NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
Back to search
Official data from USPTO
STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO)
ST13
US500000097163869Class
35, 42
Filing
97163869
Registration
7210095
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
11/07/2023
Trademark type
Word
Nice classes
35, 42
Filing date
12/09/2021
Registration date
11/07/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2023
Last transaction
11/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
2009-03-00
First use in commerce
2009-03-00
Drawing code
4
Owner type
16
Owner location
Natick, MA, US
Examiner
COUGHLAN, REBECCA D.
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boston Biotech Clinical Research, LLC
Representatives
Michelle Rosenberg PATENT GC LLC C/O CLARIVATE
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnologypharmaceuticalmedical device companiesassisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnologypharmaceuticalmedical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliancein the nature of business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceuticalbiotechnology companies to assist them with clinical researchclinical trialsapplications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trialsproviding information management services; business management and development consulting services for clinical research organizations (CRO)drug manufacturersproviding in-house and out-sourced business functions and activitiesoutsourcing services and office administration services; business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical researchclinical trialsapplications for drug approval in the fields of geneticsepigeneticbiologics and small molecule therapeuticsdrugscombination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval processall in the nature of regulatory submission managementassisting others in preparing and filing applications for new drugs with governmental regulatory bodies
Class 42
Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of designplanningimplementation project management of clinical trials
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/22/2023
PUBO
PUBLISHED FOR OPPOSITION
08/22/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/02/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/18/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/18/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/18/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/18/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/18/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/03/2023
GNFR
FINAL REFUSAL E-MAILED
05/03/2023
CNFR
FINAL REFUSAL WRITTEN
05/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/14/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/14/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/16/2022
GNRT
NON-FINAL ACTION E-MAILED
11/16/2022
CNRT
NON-FINAL ACTION WRITTEN
11/16/2022
DOCK
ASSIGNED TO EXAMINER
09/17/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/14/2021
NWAP
NEW APPLICATION ENTERED
12/13/2021
Continuous trademark protection
Get notified about every new filing that threatens STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.